Sanofi-Aventis Australia Pty Ltd - proposed acquisition of Ostelin brands from Reckitt Benckiser Australia Pty Ltd
Type of assessment
Informal Review
Reference
36633
Acquirer(s)
Sanofi-Aventis Australia Pty Ltd
Target(s)
Ostelin brands from Reckitt Benckiser Australia Pty Ltd
Industry
Pharmaceuticals
Summary
Sanofi-Aventis Australia Pty Ltd proposed to acquire Ostelin brands from Reckitt Benckiser Australia Pty Ltd.
Outcome of assessment
Not opposed
Total review days *
7
Commenced public review
3rd July 2009
Date completed
13th July 2009
Market definition
The ACCC considered the competitive effects of the proposed acquisition in the context of:
- the national market for the wholesale supply of calcium supplements; and
- the national market for the wholesale supply of vitamin D supplements.
However, the ACCC recognised that the results of the analysis would have been unchanged, regardless of the market definition adopted.
Competition analysis
The ACCC formed the view that the proposed acquisition was unlikely to substantially lessen competition in the relevant markets. Factors informing this conclusion included:
- the merged entity would continue to be constrained by existing and potential competitors;
- barriers to entry and expansion are low; and
- the relevant markets are dynamic.
Review timeline
Date
Event
3rd July 2009
ACCC commenced review under the Merger Review Process Guidelines.
10th July 2009
Closing date for submissions from interested parties.
13th July 2009
ACCC announced it would not oppose the proposed acquisition.
* Total Review days = Total business days less public holidays and time during which the review was suspended.
